Press Releases
Orchid Pharma receives US FDA approval for Olanzapine Tabs ANDA
Chennai, India
| April 25, 2012
The Chennai-based global pharma major,
Orchid Chemicals & Pharmaceuticals Ltd (Orchid Pharma) today announced that it has
received approval from the
US FDA for its ANDA (Abbreviated New Drug Application) for
Olanzapine Tablets in the 2.5 mg, 5 mg, 7.5 mg, 10 mg, 15 mg and 20 mg strengths.
Olanzapine tablets are the generic equivalent of
Eli Lilly’s Zyprexa® tablets. For the twelve months ending December 31, 2011 the total sales for this product in the US were approximately
US$ 3.3 billion. (Source: IMS Health, MAT 2011).